|
Volumn 6, Issue , 2007, Pages
|
Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
APOLIPOPROTEIN B100;
ATORVASTATIN;
CHOLESTEROL;
ENFUVIRTIDE;
EZETIMIBE;
FENOFIBRATE;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LOW DENSITY LIPOPROTEIN;
NICOTINIC ACID;
PRAVASTATIN;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ROSUVASTATIN;
TRIACYLGLYCEROL;
ANTIRETROVIRUS AGENT;
AZETIDINE DERIVATIVE;
FLUOROBENZENE;
HEPTANOIC ACID DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SULFONAMIDE;
ADD ON THERAPY;
ADULT;
AGED;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
DYSLIPIDEMIA;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
PARAMETER;
RETROSPECTIVE STUDY;
BLOOD;
HYPERLIPIDEMIA;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTI-RETROVIRAL AGENTS;
ANTICHOLESTEREMIC AGENTS;
ANTILIPEMIC AGENTS;
APOLIPOPROTEIN B-100;
AZETIDINES;
CHOLESTEROL;
FEMALE;
FLUOROBENZENES;
HEPTANOIC ACIDS;
HIV INFECTIONS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
LIPOPROTEINS, HDL;
LIPOPROTEINS, LDL;
MALE;
MIDDLE AGED;
PRAVASTATIN;
PROTEASE INHIBITORS;
PYRIMIDINES;
PYRROLES;
RETROSPECTIVE STUDIES;
SULFONAMIDES;
TREATMENT OUTCOME;
TRIGLYCERIDES;
|
EID: 34447626869
PISSN: None
EISSN: 1476511X
Source Type: Journal
DOI: 10.1186/1476-511X-6-15 Document Type: Article |
Times cited : (47)
|
References (9)
|